|
1
|
Vinay K, Abul KA, Nelson F and Richard M:
Robbins: Basic Pathology. 8th edition. Saunders; Philadelphia, PA:
2007
|
|
2
|
LiVolsi VA: Pathology of thyroid disease.
Thyroid Disease: Endocrinology, Surgery, Nuclear Medicine and
Radiotherapy. Falk SA: Lippincott-Raven; Philadelphia, PA: pp.
127–175. 1997
|
|
3
|
DeLellis RA and Williams ED: Thyroid and
parathyroid tumours. World Health Organization Classification of
Tumours. Pathology and Genetics. Tumours of Endocrine Organs.
DeLellis RA, Lloyd RV, Heitz PU and Eng C: IARC Press; Lyon: pp.
51–56. 2004
|
|
4
|
Sobrinho-Simoes M, Albores-Saavedra J and
Tallini G: Poorly dirrerentiated carcinoma. World Health
Organization Classification of Tumours. Pathology and Genetics.
Tumours of Endocrine Organs. DeLellis RA, Lloyd RV, Heitz PU and
Eng C: IARC Press; Lyon: pp. 73–76. 2004
|
|
5
|
Ito Y, Hirokawa M, Higashiyama T, Takamura
Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K and Miyauchi A:
Prognosis and prognostic factors of follicular carcinoma in Japan:
importance of postoperative pathological examination. World J Surg.
31:1417–1424. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen CZ: MicroRNAs as oncogenes and tumor
suppressors. N Engl J Med. 353:1768–1771. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Iorio MV, Ferracin M, Liu CG, Veronese A,
Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M,
Menard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I,
Calin GA, Querzoli P, Neqrini M and Croce CM: MicroRNA gene
expression deregulation in human breast cancer. Cancer Res.
65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Murakami Y, Yasuda T, Saigo K, Urashima T,
Toyoda H, Okanoue T and Shimotohno K: Comprehensive analysis of
microRNA expression patterns in hepatocellular carcinoma and
non-tumorous tissues. Oncogene. 25:2537–2545. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Calin GA, Ferracin M, Cimmino A, Di Leva
G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M,
Iuliano R, Palumbo T, Pichiorri F, Roldo C, Garzon R, Sevignani C,
Rassenti L, Alder H, Volnia S, Liu CG, Kipps TJ, Negrini M and
Croce CM: A microRNA signature associated with prognosis and
progression in chronic lymphocytic leukemia. N Engl J Med.
353:1793–1801. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yanaihara N, Caplen N, Bowman E, Seike M,
Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin
GA, Liu CG, Croce CM and Harris CC: Unique microRNA molecular
profiles in lung cancer diagnosis and prognosis. Cancer Cell.
9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Visone R, Russo L, Pallante P, De Martino
I, Ferraro A, Leone V, Borbone E, Petrocca F, Alder H, Croce CM and
Fusco A: MicroRNAs(miR)-221 and miR-222, both overexpressed in
human thyroid papillary carcinomas, regulate p27Kip1
protein levels and cell cycle. Endocr Relat Cancer. 14:791–798.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pallante P, Visone R, Croce CM and Fusco
A: Deregulation of microRNA expression in follicular cell-derived
human thyroid carcinomas. Endocr Relat Cancer. 17:F91–F104. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mazeh H, Mizrahi I, Halle D, Ilyayev N,
Stojadinovic A, Trink B, Mitrani-Rosenbaum S, Roistacher M, Ariel
I, Eid A, Freund HR and Nissan A: Development of a microRNA-based
molecular assay for the detection of papillary thyroid carcinoma in
aspiration biopsy samples. Thyroid. 21:111–118. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hair JF Jr, Anderson RE, Tatham RL and
Black WC: Multivariate Data Analysis with Readings. 4th edition.
Prentice-Hall; Englewood Cliffs: 1995
|
|
16
|
Cohen J, Cohen P, West SG and Aiken LS:
Applied Multiple Regression/Correlation Analysis for the Behavioral
Sciences. 3rd edition. Lawrence Erlbaum Associates; Mahwah, NJ:
2003
|
|
17
|
Guthrie JL, Seah C, Brown S, Tang P,
Jamieson F and Drews SJ: Use of Bordetella pertussis BP3385 to
establish a cutoff value for an IS481-targeted real-time PCR assay.
J Clin Microbiol. 46:3798–3799. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xi Y, Nakajima G, Gavin E, Morris CG, Kudo
K, Hayashi K and Ju J: Systematic analysis of microRNA expression
of RNA extracted from fresh frozen and formalin-fixed
paraffin-embedded samples. RNA. 13:1668–1674. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cronin M, Pho M, Dutta D, Stephans JC,
Shak S, Kiefer MC, Esteban JM and Baker JB: Measurement of gene
expression in archival paraffin-embedded tissues: development and
performance of a 92-gene reverse transcriptase-polymerase chain
reaction assay. Am J Pathol. 164:35–42. 2004. View Article : Google Scholar
|
|
20
|
Masuda N, Ohnishi T, Kawamoto S, Monden M
and Okubo K: Analysis of chemical modification of RNA from
formalin-fixed samples and optimization of molecular biology
applications for such samples. Nucleic Acids Res. 27:4436–4443.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Srinivasan M, Sedmak D and Jewell S:
Effect of fixatives and tissue processing on the content and
integrity of nucleic acids. Am J Pathol. 161:1961–1971. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nikiforova MN, Tseng GC, Steward D, Diorio
D and Nikiforov YE: MicroRNA expression profiling of thyroid
tumors: biological significance and diagnostic utility. J Clin
Endocrinol Metab. 93:1600–1608. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Takano T, Miyauchi A, Yoshida H, Kuma k
and Amino N: High-throughput differential screening of mRNAs by
serial analysis of gene expression: decreased expression of trefoil
factor 3 mRNA in thyroid follicular carcinomas. Br J Cancer.
90:1600–1605. 2004. View Article : Google Scholar
|
|
24
|
Foukakis T, Gusnanto A, Au AY, Höög A, Lui
WO, Larsson C, Wallin G and Zedenius J: A PCR-based expression
signature of malignancy in follicular thyroid tumors. Endocr Relat
Cancer. 14:381–391. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lu J, Getz G, Miska EA, Alvarz-Saavedra E,
Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
Downing JR, Jacks T, Horvitz HR and Golub TR: MicroRNA expression
profiles classify human cancers. Nature. 435:834–838. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Galardi S, Mercatelli N, Giorda E,
Massalini S, Frajese GV, Ciafere SA and Farace MG: miR-221 and
miR-222 expression affects the proliferation potential of human
prostate carcinoma cell lines by targeting p27Kip1. J
Biol Chem. 282:23716–23724. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Miller TE, Ghoshal K, Ramaswamy B, Roy S,
Datta J, Shapiro CL, Jacob S and Majumder S: MicroRNA-221/222
confers tamoxifen resistance in breast cancer by targeting
p27Kip1. J Biol Chem. 283:29897–29903. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang C, Han L, Zhag A, Yang W, Zhou X, Pu
P, Du Y, Zeng H and Kang C: Global changes of mRNA expression
reveals an increased activity of the interferon-induced signal
transducer and activator of transcription (STAT) pathway by
repression of miR-221/222 in glioblastoma U251 cells. Int J Oncol.
36:1503–1512. 2010.
|
|
29
|
Le Sage C, Nagel R, Egan DA, Schrier M,
Mesman E, Mangiola A, Anile C, Maira G, Mercatelli N, Ciafre SA,
Farace MG and Agami R: Regulation of the p27(Kip1) tumor suppressor
by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J.
26:3699–3708. 2007.PubMed/NCBI
|
|
30
|
Fornari F, Gramantieri L, Ferracin M,
Veronese A, Sabbiori S, Calin GA, Grazi GL, Giovannini C, Croce CM,
Bolondi L and Negrini M: MiR-221 controls CDKN1C/p57 and CDKN1B/p27
expression in human hepatocellular carcinoma. Oncogene.
27:5651–5661. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
He H, Jazdzewski K, Li W, Liyanarachchi S,
Nagy R, Volinia S, Calin GA, Liu CG, Franssila K, Suster S, Kloos
RT, Croce CM and de la Chapelle A: The role of microRNA genes in
papillary thyroid carcinoma. Proc Natl Acad Sci USA.
102:19075–19080. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ma L, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tan HX, Wang Q, Chen LZ, Huang XH, Chen
JS, Fu XH, Cao LQ, Chen XL, Li W and Zhang LJ: MicroRNA-9 reduces
cell invasion and E-cadherin secretion in SK-Hep-1 cell. Med Oncol.
27:654–660. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bloomston M, Frankel WL, Petrocca F,
Volinia S, Alder H, Hagan JP, Liu CG, Bhatt D, Taccioli C and Croce
CM: MicroRNA expression patterns to differentiate pancreatic
adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA.
297:1901–1908. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ciafre SA, Galardi S, Mangiola A, Ferracin
M, Liu CG, Sabatino G, Negrini M, Maira G, Croce CM and Farace MG:
Extensive modulation of a set of microRNAs in primary glioblastoma.
Biochem Biophys Res Commun. 334:1351–1358. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Huse JT, Brennan C, Hambardzumyan D, Wee
B, Pena J, Rouhanifard SH, Sohn-Lee C, le Sage C, Agami R, Tuschl T
and Holland EC: The PTEN-regulating microRNA miR-26a is amplified
in high-grade glioma and facilitates gliomagenesis in vivo. Genes
Dev. 23:1327–1337. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sun L, Yan W, Wang Y, Sun G, Luo H, Zhang
J, Wang X, You Y, Yang Z and Liu N: MicroRNA-10b induces glioma
cell invasion by modulating MMP-14 and uPAR expression via HOXD10.
Brain Res. 1389:9–18. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ma L and Weinberg RA: Micromanagers of
malignancy: role of microRNAs in regulating metastasis. Trends
Genet. 24:448–456. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ota A, Tagawa H, Karnan S, Tsuzuki S,
Karpas A, Kira S, Yoshida Y and Seto M: Identification and
characterization of a novel gene, C13orf25, as a target for
13q31-q32 amplification in malignant lymphoma. Cancer Res.
64:3087–3095. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hayashita Y, Osada H, Tatematsu Y, Yamada
H, Yanagisawa K, Tomida S, Yatabe Y, Kawahara K, Sekido Y and
Takahashi T: A polycistronic microRNA cluster, miR-17-92, is
overexpressed in human lung cancers and enhances cell
proliferation. Cancer Res. 65:9628–9632. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Monzo M, Navarro A, Bandres E, Artells R,
Moreno I, Gel B, Ibeas R, Moreno J, Martinez F, Diaz T, Martinez A,
Balagué O and Garcia-Foncillas J: Overlapping expression of
microRNAs in human embryonic colon and colorectal cancer. Cell Res.
18:823–833. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Diosdado B, van de Wiel MA, Terhaar Sive
Droste JS, Mongera S, Postma C, Meijerink W J, Carvalho B and
Meijer GA: MiR-17-92 cluster is associated with 13q gain and c-myc
expression during colorectal adenoma to adenocarcinoma progression.
Br J Cancer. 101:707–714. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Connolly E, Melegari M, Landgraf P,
Tchaikovskaya T, Tennant BC, Slagle BL, Rogler LE, Zavolan M,
Tuschl T and Rogler CE: Elevated expression of the miR-17-92
polycistron and miR-21 in hepadnavirus-associated hepatocellular
carcinoma contributes to the malignant phenotype. Am J Pathol.
173:856–864. 2008. View Article : Google Scholar
|
|
44
|
Chen HC, Chen GH, Chen Y H, Liao WL, Liu
CY, Chang KP, Chang YS and Chen SJ: MicroRNA deregulation and
pathway alterations in nasopharyngeal carcinoma. Br J Cancer.
100:1002–1011. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Takakura S, Mitsutake N, Nakashima M,
Namba H, Saenko VA, Rogounovitch TI, Nakazawa Y, Hayashi T, Ohtsuru
A and Yamashita S: Oncogenic role of miR-17-92 cluster in
anaplastic thyroid cancer cells. Cancer Sci. 99:147–154. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chen ZL, Zhao XH, Wang JW, Li BZ, Wang Z,
Sun J, Tan FW, Ding DP, Xu XH, Zhou F, Tan XG, Hang J, Shi SS, Feng
XL and He J: microRNA-92a promotes lymph node metastasis of human
esophageal squamous cell carcinoma via E-cadherin. J Biol Chem.
25:10725–10734. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Mete O and Asa SL: Pathological definition
and clinical significance of vascular invasion in thyroid
carcinomas of follicular epithelial derivation. Mod Pathol.
24:1545–1552. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Asari R, Koperek O, Scheuba C, Riss P,
Kaserer K, Hoffmann M and Niederle B: Follicular thyroid carcinoma
in an iodine-replete endemic goiter region: a prospectively
collected, retrospectively analyzed clinical trial. Ann Surg.
249:1023–1031. 2009. View Article : Google Scholar
|
|
49
|
Sugino K and Ito K, Nagahama M, Kitagawa
W, Shibuya H, Ohkuwa K, Yano Y, Uruno T, Akaishi J, Kameyama K and
Ito K: Prognosis and prognostic factors for distant metastases and
tumor mortality in follicular thyroid carcinoma. Thyroid.
21:751–757. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Mazzaferri EL and Jhiang SM: Long-term
impact of initial surgical and medical therapy on papillary and
follicular thyroid cancer. Am J Med. 97:418–428. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
van Heerden JA, Hay ID, Goellner JR,
Salomao D, Ebersold JR, Bergstralh EJ and Grant CS: Follicular
thyroid carcinoma with capsular invasion alone: a nonthreatening
malignancy. Surgery. 112:1130–1138. 1992.PubMed/NCBI
|
|
52
|
Thompson LD, Wieneke JA, Paal E, Frommelt
RA, Adair CF and Heffess CS: A clinicopathologic study of minimally
invasive follicular carcinoma of the thyroid gland with a review of
the English literature. Cancer. 91:505–524. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Mazafferi EL and Kloos RT: Carcinoma of
follicular epithelium: radioiodine and other treatments and
outcomes. The Thyroid. Braverman LE and Utiger RD: Lippincott
Williams & Wilkins; Philadelphia, PA: pp. 934–966. 2005
|
